Saturday, October 28, 2017

Dry Eye during Breast Cancer Treatment

Did you know that certain types of breast cancer treatment medications can cause dry eye symptoms? The class of medications called “aromatase inhibitors” (AIs) has been studied and found to cause dry eyes. Fortunately, we also know that this is a newly emerging, and easily treated side effect of AIs. But we need to know that you are taking one of the AIs in order to offer help for your dry eyes. Some of the medications in this class include Arimidex, Aromasin and Femara-although there are many others. Researchers used a validated questionnaire to assess the presence of Dry Eye Syndrome (DES). They found that DES is significantly more prevalent in women on AIs compared with controls. They recommend routine screening of patients on AIs with the Ocular Surface disease Index (OSDI) questionnaire with the aim of improving patient quality of life and possibly adherence.

If you or someone you know is being treated for breast cancer with aromatase inhibitors (AIs) and suffers from dry eyes, grittiness or is generally experiencing eye problems of fatigue or dryness, please call Alabama Eye & Cataract Center in Birmingham at 205-930-0930, visit Alabama Eye & Cataract Center, Google+ or

Michelson Laser Vision and Alabama Eye & Cataract Center are leading eye care centers in Birmingham located at UAB-Highlands, 1201 11th Avenue S, Suite 501, Birmingham, Alabama 35205 and staffed by UAB Medicine eye doctors and eye specialists.